Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH), 46997-46998 [E9-21991]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 176 / Monday, September 14, 2009 / Notices
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
cprice-sewell on DSK2BSOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIDDK.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Diabetes and
Digestive and Kidney Diseases,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDDK.
Date: October 15–16, 2009.
Time: October 15, 2009, 8:15 a.m. to 3:50
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Conference
Room 9S235, Bethesda, MD 20892.
Time: October 16, 2009, 8:15 a.m. to 4:45
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Conference
Room 9S235 Bethesda, MD 20892.
Contact Person: Ira W. Levin, PhD,
Director, Division of Intramural Research,
National Institute of Diabetes and Digestive
and Kidney Diseases, NIH, Bethesda, MD
20892, 301–496–6844, iwl@helix.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
VerDate Nov<24>2008
15:23 Sep 11, 2009
Jkt 217001
Dated: September 3, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–21997 Filed 9–11–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Cell Bank.
Date: October 8, 2009.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20814 (Telephone
Conference Call).
Contact Person: Alicja L Markowska, PhD,
DSC, Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
7201 Wisconsin Avenue, Suite 2C212,
Bethesda, MD 20892. 301–496–9666.
markowska@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Genetics of
Aging in Drosophila.
Date: October 20, 2009.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Elaine Lewis, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Building, Suite 2C212, MSC–9205, 7201
Wisconsin Avenue, Bethesda, MD 20892.
301–402–7707. elainelewis@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel,
Neuroendocrine and Reproductive Aging.
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
46997
Date: December 2, 2009.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892. (Telephone
Conference Call).
Contact Person: Rebecca J. Ferrell, PhD,
Scientific Review Officer, National Institute
on Aging, Gateway Building 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892.
301–402–7703. ferrellrj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: September 3, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–21999 Filed 9–11–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
Safety and Occupational Health Study
Section (SOHSS), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC announces the
following meeting of the
aforementioned committee:
Times and Dates: 8 a.m.–5 p.m., October
13, 2009 (Closed). 8 a.m.–5 p.m., October 14,
2009 (Closed).
Place: Embassy Suites Hotel, 1900
Diagonal Road, Alexandria, Virginia 22314,
Telephone (703) 684–5900, Fax (703) 684–
1403.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Purpose: The Safety and Occupational
Health Study section will review, discuss,
and evaluate grant application(s) received in
response to the Institute’s standard grants
review and funding cycles pertaining to
research issues in occupational safety and
health, and allied areas.
It is the intent of NIOSH to support broadbased research endeavors in keeping with the
Institute’s program goals. This will lead to
improved understanding and appreciation for
the magnitude of the aggregate health burden
associated with occupational injuries and
illnesses, as well as to support more focused
research projects, which will lead to
improvements in the delivery of occupational
safety and health services, and the
prevention of work-related injury and illness.
It is anticipated that research funded will
promote these program goals.
E:\FR\FM\14SEN1.SGM
14SEN1
46998
Federal Register / Vol. 74, No. 176 / Monday, September 14, 2009 / Notices
Matters to be Discussed: The meeting will
convene to address matters related to the
conduct of Study section business and for the
study section to consider safety and
occupational health-related grant
applications. Agenda items are subject to
change as priorities dictate.
Contact Person for More Information: Price
Connor, PhD, NIOSH Health Scientist, 1600
Clifton Road, NE., Mailstop E–20, Atlanta,
Georgia 30333, Telephone (404) 498–2511,
Fax (404) 498–2571.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: September 3, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–21991 Filed 9–11–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
cprice-sewell on DSK2BSOYB1PROD with NOTICES
Office of the Director, National
Institutes of Health; Notice of Public
Forums
Notice is hereby given of two forums
of the working groups of the NIH
Scientific Management Review Board:
Deliberating Organizational Changes
and Effectiveness Working Group and
Substance Use, Abuse and Addition
Working Group. The forums will serve
as the first among a series of sessions for
gathering information on the agency’s
organizational structure and
recommendations for enhancing the
NIH mission through greater agency
flexibility and responsiveness.
The forums will be open to the public,
with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The input from these meetings will be
summarized in a report that will be
presented to the Scientific Management
Review Board in open session at an
upcoming meeting.
Name of Committee: Substance Use,
Abuse, and Addiction Working Group of the
Scientific Management Review Board.
Date: September 23, 2009.
Open: 8 a.m. to 3 p.m.
Agenda: Presentation and discussion will
include an overview of the science of
substance use, abuse, and addiction and the
public health needs in this area of research.
VerDate Nov<24>2008
15:23 Sep 11, 2009
Jkt 217001
Place: National Institutes of Health,
Building 60, Chapel and Lecture Hall, 9000
Rockville Pike, Bethesda, MD 20892.
Name of Committee: Deliberating
Organizational Change and Effectiveness
Working Group of the Scientific Management
Review Board.
Date: September 24, 2009.
Open: 8 a.m. to 3 p.m.
Agenda: Presentations and discussion will
include an overview of NIH mission and
function from scientific and stakeholder
perspectives, including elaboration upon the
principles and attributes fundamental to its
success.
Place: National Institutes of Health,
Building 60, Chapel and Lecture Hall, 9000
Rockville Pike, Bethesda, MD 20892.
Contact Person: Dr. Lyric Jorgenson, PhD,
NIH–AAAS Science and Technology Policy
Fellow, Office of Science Policy, Office of the
Director, NIH, National Institutes of Health,
Building 1, Room 218, MSC 0166, 9000
Rockville Pike, Bethesda, MD 20892,
smrb@mail.nih.gov, (301) 496–6837.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person. The
meeting will also be webcast. The draft
meeting agenda and other information about
the SMRB, including information about
access to the webcast, will be available at
https://smrb.od.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Dated: August 28, 2009.
Lynn Hudson,
Acting Director, Office of Biotechnology
Activities.
[FR Doc. E9–22000 Filed 9–11–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Child Health and Human Development
Council, September 21, 2009, 8 a.m. to
September 21, 2009, 5 p.m., National
Institutes of Health, Building 31, 31
Center Drive, Bethesda, MD 20892
which was published in the Federal
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Register on September 1, 2009, 74 FR
54224.
This notice is being amended to
provide additional attendee viewing and
Videocast access instructions for open
session of Council. In order to facilitate
public attendance at the open session of
Council, reserve seating will be made
available to the first five individuals
reserving seats in the main meeting
room, Conference Room 6. Please
Contact Ms. Lisa Kaeser, Program and
Public Liaison Office, NICHD, at 301–
496–0536 to make your reservation.
Additional seating will be available in
the meeting overflow rooms, Conference
Rooms 7 and 8. Individuals will also be
able to view the meeting via NIH
Videocast. Please go to the following
link for Videocast access instructions at:
https://www.nichd.nih.gov/about/
overview/advisory/nachhd/virtualmeeting-200910.cfm. The meeting is
partially closed to the public.
Dated: September 3, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–21998 Filed 9–11–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0667]
[FDA 225–09–0010]
Memorandum of Understanding With
Duke University
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is providing
notice of a memorandum of
understanding (MOU) between the Food
and Drug Administration and Duke
University. The purpose of this MOU is
to establish a framework for
collaboration between the Parties and
for pursuing specific collaborative
projects. This collaboration between the
Parties shall be known as the Cardiac
Safety Research Consortium.
DATES: The agreement became effective
August 4, 2009.
FOR FURTHER INFORMATION CONTACT:
Wendy R. Sanhai, Office of the
Commissioner (HZ–1), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–7867,
FAX: 301–827–5891.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 20.108(c),
E:\FR\FM\14SEN1.SGM
14SEN1
]]>Agencies
[Federal Register Volume 74, Number 176 (Monday, September 14, 2009)]
[Notices]
[Pages 46997-46998]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-21991]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Safety and Occupational Health Study Section (SOHSS), National
Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), CDC announces the following meeting of
the aforementioned committee:
Times and Dates: 8 a.m.-5 p.m., October 13, 2009 (Closed). 8
a.m.-5 p.m., October 14, 2009 (Closed).
Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria,
Virginia 22314, Telephone (703) 684-5900, Fax (703) 684-1403.
Status: The meeting will be closed to the public in accordance
with provisions set forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Purpose: The Safety and Occupational Health Study section will
review, discuss, and evaluate grant application(s) received in
response to the Institute's standard grants review and funding
cycles pertaining to research issues in occupational safety and
health, and allied areas.
It is the intent of NIOSH to support broad-based research
endeavors in keeping with the Institute's program goals. This will
lead to improved understanding and appreciation for the magnitude of
the aggregate health burden associated with occupational injuries
and illnesses, as well as to support more focused research projects,
which will lead to improvements in the delivery of occupational
safety and health services, and the prevention of work-related
injury and illness. It is anticipated that research funded will
promote these program goals.
[[Page 46998]]
Matters to be Discussed: The meeting will convene to address
matters related to the conduct of Study section business and for the
study section to consider safety and occupational health-related
grant applications. Agenda items are subject to change as priorities
dictate.
Contact Person for More Information: Price Connor, PhD, NIOSH
Health Scientist, 1600 Clifton Road, NE., Mailstop E-20, Atlanta,
Georgia 30333, Telephone (404) 498-2511, Fax (404) 498-2571.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: September 3, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-21991 Filed 9-11-09; 8:45 am]
BILLING CODE 4163-18-P
